The Apex Times
Above the Noise
Business Wire
BusinessTesla’s Roadster gets a second life in SpaceX orbit talk, after Yahoo Finance-linked “Halo” referenceThe Apex TimesBusinessBroadcom and Verizon join other firms in challenging tokenized stock listings tied to their sharesThe Apex TimesBusinessMotley Fool frames Oct. 30 as a key date for long-term Costco holders, pointing to dividends and price gainsThe Apex TimesBusinessCoca-Cola’s 2.3% yield and Nike’s 4.4% yield put dividend investors in a trade-off, analysts sayThe Apex TimesBusinessBoeing reports third-quarter delivery totals as Wall Street watches FAA approval timingThe Apex TimesBusinessMeta earnings in focus as investors weigh AI demand worries after Nasdaq weaknessThe Apex TimesBusinessDisney to absorb most of Character.AI staff after the chatbot startup’s bankruptcy filingThe Apex TimesBusinessNvidia’s November track record is strong, but one variable could disrupt the pattern, market note saysThe Apex TimesBusinessDividend debate revisits PepsiCo and Philip Morris after Philip Morris lifts quarterly payoutThe Apex TimesBusinessAlphabet investors weigh AI-chip optimism after a Wall Street call for a potential 20% upsideThe Apex TimesBusinessBroadcom (AVGO) is likely to face tough competition for advanced AI chip manufacturing capacity as TSMC ramps in 2026, according to market coverageThe Apex TimesBusinessNetflix cuts 1,000 jobs, leaving questions about what changes subscribers could actually seeThe Apex TimesBusinessTesla’s Roadster gets a second life in SpaceX orbit talk, after Yahoo Finance-linked “Halo” referenceThe Apex TimesBusinessBroadcom and Verizon join other firms in challenging tokenized stock listings tied to their sharesThe Apex TimesBusinessMotley Fool frames Oct. 30 as a key date for long-term Costco holders, pointing to dividends and price gainsThe Apex TimesBusinessCoca-Cola’s 2.3% yield and Nike’s 4.4% yield put dividend investors in a trade-off, analysts sayThe Apex TimesBusinessBoeing reports third-quarter delivery totals as Wall Street watches FAA approval timingThe Apex TimesBusinessMeta earnings in focus as investors weigh AI demand worries after Nasdaq weaknessThe Apex TimesBusinessDisney to absorb most of Character.AI staff after the chatbot startup’s bankruptcy filingThe Apex TimesBusinessNvidia’s November track record is strong, but one variable could disrupt the pattern, market note saysThe Apex TimesBusinessDividend debate revisits PepsiCo and Philip Morris after Philip Morris lifts quarterly payoutThe Apex TimesBusinessAlphabet investors weigh AI-chip optimism after a Wall Street call for a potential 20% upsideThe Apex TimesBusinessBroadcom (AVGO) is likely to face tough competition for advanced AI chip manufacturing capacity as TSMC ramps in 2026, according to market coverageThe Apex TimesBusinessNetflix cuts 1,000 jobs, leaving questions about what changes subscribers could actually seeThe Apex TimesBusinessTesla’s Roadster gets a second life in SpaceX orbit talk, after Yahoo Finance-linked “Halo” referenceThe Apex TimesBusinessBroadcom and Verizon join other firms in challenging tokenized stock listings tied to their sharesThe Apex TimesBusinessMotley Fool frames Oct. 30 as a key date for long-term Costco holders, pointing to dividends and price gainsThe Apex TimesBusinessCoca-Cola’s 2.3% yield and Nike’s 4.4% yield put dividend investors in a trade-off, analysts sayThe Apex TimesBusinessBoeing reports third-quarter delivery totals as Wall Street watches FAA approval timingThe Apex TimesBusinessMeta earnings in focus as investors weigh AI demand worries after Nasdaq weaknessThe Apex TimesBusinessDisney to absorb most of Character.AI staff after the chatbot startup’s bankruptcy filingThe Apex TimesBusinessNvidia’s November track record is strong, but one variable could disrupt the pattern, market note saysThe Apex TimesBusinessDividend debate revisits PepsiCo and Philip Morris after Philip Morris lifts quarterly payoutThe Apex TimesBusinessAlphabet investors weigh AI-chip optimism after a Wall Street call for a potential 20% upsideThe Apex TimesBusinessBroadcom (AVGO) is likely to face tough competition for advanced AI chip manufacturing capacity as TSMC ramps in 2026, according to market coverageThe Apex TimesBusinessNetflix cuts 1,000 jobs, leaving questions about what changes subscribers could actually seeThe Apex TimesBusinessTesla’s Roadster gets a second life in SpaceX orbit talk, after Yahoo Finance-linked “Halo” referenceThe Apex TimesBusinessBroadcom and Verizon join other firms in challenging tokenized stock listings tied to their sharesThe Apex TimesBusinessMotley Fool frames Oct. 30 as a key date for long-term Costco holders, pointing to dividends and price gainsThe Apex TimesBusinessCoca-Cola’s 2.3% yield and Nike’s 4.4% yield put dividend investors in a trade-off, analysts sayThe Apex TimesBusinessBoeing reports third-quarter delivery totals as Wall Street watches FAA approval timingThe Apex TimesBusinessMeta earnings in focus as investors weigh AI demand worries after Nasdaq weaknessThe Apex TimesBusinessDisney to absorb most of Character.AI staff after the chatbot startup’s bankruptcy filingThe Apex TimesBusinessNvidia’s November track record is strong, but one variable could disrupt the pattern, market note saysThe Apex TimesBusinessDividend debate revisits PepsiCo and Philip Morris after Philip Morris lifts quarterly payoutThe Apex TimesBusinessAlphabet investors weigh AI-chip optimism after a Wall Street call for a potential 20% upsideThe Apex TimesBusinessBroadcom (AVGO) is likely to face tough competition for advanced AI chip manufacturing capacity as TSMC ramps in 2026, according to market coverageThe Apex TimesBusinessNetflix cuts 1,000 jobs, leaving questions about what changes subscribers could actually seeThe Apex Times
Back to front
CVS Health appears on Larry Robbins’ dividend-stock list as analyst price target rises
The Apex Times

THE APEX TIMES

Business/The Apex Times/Jun 15, 1:40 AM EDT

CVS Health appears on Larry Robbins’ dividend-stock list as analyst price target rises

A Yahoo Finance roundup says CVS Health is among billionaire Larry Robbins’ 10 dividend stock picks, alongside a separate update from Morgan Stanley that lifted its CVS price recommendation this week.

By The Apex Times Newsroom2 min readAI-assisted Apex article

CVS Health is drawing fresh attention in dividend-focused circles, after a Yahoo Finance report included the company among billionaire Larry Robbins’ 10 dividend stock picks. The list frames CVS as a candidate for long-term income investors, reflecting the broader appeal of mature, cash-generating healthcare and retail pharmacy businesses.

The same Yahoo Finance item also points to a separate sell-side development. On June 4, Morgan Stanley raised its price recommendation on CVS Health to $111 from $106, according to the report.

In practical terms, a raised price target indicates that an analyst expects more favorable fundamentals than previously projected, though it does not guarantee a specific stock move. The step up from $106 to $111 suggests Morgan Stanley’s view of CVS’s near- and medium-term outlook has improved since its prior assessment.

CVS operates across healthcare services and insurance, with a large retail footprint in prescription dispensing and related consumer health offerings. The stock often trades with investors who weigh steady demand for medications and services against risks tied to reimbursement rates, benefit design changes, and the competitive dynamics of the pharmacy and managed care markets.

Dividend-stock screening like Robbins’ typically emphasizes a company’s capacity to produce cash that can support ongoing shareholder payouts. In that context, CVS’s inclusion is less about a single quarter’s results and more about the perception that its earnings power and capital discipline can persist across business cycles.

Still, the Yahoo Finance post provides limited detail beyond the list inclusion and the analyst price update. It does not lay out the specific dividend criteria Robbins and his team used, nor does it provide new company disclosures explaining what underpins Morgan Stanley’s adjustment.

For investors watching CVS from a dividend perspective, the next meaningful checkpoints are likely to be updates on earnings and cash flow, plus any guidance around medical costs, pharmacy profitability, and the pace of spend in its healthcare services segments. Analyst revisions can also continue to act as a barometer for whether Wall Street’s assumptions are converging on a more durable outlook.

Why It Matters

  • Inclusion on a dividend-focused list can increase attention from income-oriented investors, even when it is not tied to a new operational announcement.
  • Analyst price-target lifts can influence sentiment, especially for stocks that trade partly on forward earnings expectations.
  • With limited disclosure in the cited post, market participants may look to upcoming financial results to confirm whether the optimism is supported by fundamentals.

Sources

Key Facts

  • A Yahoo Finance report lists CVS Health among billionaire Larry Robbins’ 10 dividend stock picks.
  • The same report says Morgan Stanley raised its price recommendation on CVS Health on June 4 to $111 from $106.
  • The reported analyst change reflects an improved valuation view versus the prior Morgan Stanley level.
  • The Yahoo Finance item, as presented, does not include detailed company-specific rationale for Robbins’ dividend selection or the full reasoning for Morgan Stanley’s adjustment.

Healthcare Related

Oct 18, 10:57 AM EDT
The Apex Times

Eli Lilly Shares Outperform as Investors Bet on Longevity and Pipeline Momentum

Eli Lilly (LLY) has gained about 36% over six months through October 15, according to Yahoo Finance, widening the gap versus broad-market and a commonly tracked billionaire basket. The move highlights how much near-term expectations hinge on new growth catalysts in healthcare.

Eli Lilly Shares Outperform as Investors Bet on Longevity and Pipeline Momentum
The Apex Times
CVS Health appears on Larry Robbins’ dividend-stock list as analyst price target rises | The Apex Times